Skip to content

Etiology and treatment strategies for pediatric blepherokeratoconjunctivitis

Etiology and treatment strategies for pediatric blepherokeratoconjunctivitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015604
Enrollment
Unknown
Registered
2018-04-11
Start date
2018-04-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blepherokeratoconjunctivitis

Interventions

tobramycin-dexamethasone clean group:0.3%tobramycin-0.1%dexamethasone ointment, OCuSOFT Plus Eyelid Cleanser
tobramycin-dexamethasone unclean group:0.3%tobramycin-0.1%dexamethasone ointment
tobramycin clean group :0.3% tobramycin ointment, OCuSOFT Plus Eyelid Cleanser
tobramycin unclean group:0.3% tobramycin ointment

Sponsors

Peking Unversity Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Children from 1-14 years old; 2. Children having been definitely diagnosed as blepharitis based on clinical manifestations, accompanied with cornea and conjunctiva lesion in accordance with the scores of symptoms, physical signs and cornea and conjunctiva lesion; 3. Children without any contraindications; 4. Children and their parents with good compliance willing to obey the clinical study protocol and cooperating with the examination, agreeing and signing the Informed Consent Forms;

Exclusion criteria

Exclusion criteria: 1. Those sensitive to the medicine ingredients; 2. Those with severe heart, lung, hepatic and renal dysfunction or severe congenital diseases; 3. Those with combined with glaucoma and retinopathy, etc. who would possibly face the progressing eye diseases in the course of test; 4. Those in combined use of other drugs that may possibly affect the curative effect and safety evaluation of this research.

Design outcomes

Primary

MeasureTime frame
visual acurity;intraocular pressure;BUT;corneal fluorescein staining;symptoms;blepharitis signs;keratitis signs;conjunctivitis signs;

Countries

China

Contacts

Public ContactHong Jing

Peking Unversity Third Hospital

hongjing1964@sina.com+86 13910573646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026